214 related articles for article (PubMed ID: 18364727)
1. Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke.
Doyle KP; Yang T; Lessov NS; Ciesielski TM; Stevens SL; Simon RP; King JS; Stenzel-Poore MP
J Cereb Blood Flow Metab; 2008 Jun; 28(6):1235-48. PubMed ID: 18364727
[TBL] [Abstract][Full Text] [Related]
2. Intranasal Delivery of RGD Motif-Containing Osteopontin Icosamer Confers Neuroprotection in the Postischemic Brain via αvβ3 Integrin Binding.
Jin YC; Lee H; Kim SW; Kim ID; Lee HK; Lee Y; Han PL; Lee JK
Mol Neurobiol; 2016 Oct; 53(8):5652-63. PubMed ID: 26482372
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection by osteopontin in stroke.
Meller R; Stevens SL; Minami M; Cameron JA; King S; Rosenzweig H; Doyle K; Lessov NS; Simon RP; Stenzel-Poore MP
J Cereb Blood Flow Metab; 2005 Feb; 25(2):217-25. PubMed ID: 15678124
[TBL] [Abstract][Full Text] [Related]
4. The effect of osteopontin and osteopontin-derived peptides on preterm brain injury.
Albertsson AM; Zhang X; Leavenworth J; Bi D; Nair S; Qiao L; Hagberg H; Mallard C; Cantor H; Wang X
J Neuroinflammation; 2014 Dec; 11():197. PubMed ID: 25465048
[TBL] [Abstract][Full Text] [Related]
5. Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain.
Senger DR; Perruzzi CA; Papadopoulos-Sergiou A; Van de Water L
Mol Biol Cell; 1994 May; 5(5):565-74. PubMed ID: 7522656
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D.
Christensen B; Schack L; Kläning E; Sørensen ES
J Biol Chem; 2010 Mar; 285(11):7929-37. PubMed ID: 20071328
[TBL] [Abstract][Full Text] [Related]
7. The neonatal brain is not protected by osteopontin peptide treatment after hypoxia-ischemia.
Bonestroo HJ; Nijboer CH; van Velthoven CT; van Bel F; Heijnen CJ
Dev Neurosci; 2015; 37(2):142-52. PubMed ID: 25765537
[TBL] [Abstract][Full Text] [Related]
8. Identification of dual alpha 4beta1 integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin.
Bayless KJ; Davis GE
J Biol Chem; 2001 Apr; 276(16):13483-9. PubMed ID: 11278897
[TBL] [Abstract][Full Text] [Related]
9. Intranasal Delivery of RGD-Containing Osteopontin Heptamer Peptide Confers Neuroprotection in the Ischemic Brain and Augments Microglia M2 Polarization.
Davaanyam D; Kim ID; Lee JK
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576163
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin is highly susceptible to cleavage in bovine milk and the proteolytic fragments bind the αVβ₃-integrin receptor.
Christensen B; Sørensen ES
J Dairy Sci; 2014; 97(1):136-46. PubMed ID: 24268404
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of intranasally administered nanoparticles-mediated neuroprotective peptide NR2B9c to brain and neuron for treatment of ischemic stroke.
Li R; Huang Y; Chen L; Zhou H; Zhang M; Chang L; Shen H; Zhou M; Su P; Zhu D
Nanomedicine; 2019 Jun; 18():380-390. PubMed ID: 30428334
[TBL] [Abstract][Full Text] [Related]
12. Methods to Investigate Thrombin Cleavage of Osteopontin (OPN).
Zhao L; Leung LL; Morser J
Methods Mol Biol; 2024; 2747():95-117. PubMed ID: 38038935
[TBL] [Abstract][Full Text] [Related]
13. Acute intranasal osteopontin treatment in male rats following TBI increases the number of activated microglia but does not alter lesion characteristics.
Jullienne A; Hamer M; Haddad E; Morita A; Gifford P; Hartman R; Pearce WJ; Tang J; Zhang JH; Obenaus A
J Neurosci Res; 2020 Jan; 98(1):141-154. PubMed ID: 30892744
[TBL] [Abstract][Full Text] [Related]
14. Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragments.
Gao YA; Agnihotri R; Vary CP; Liaw L
Matrix Biol; 2004 Nov; 23(7):457-66. PubMed ID: 15579312
[TBL] [Abstract][Full Text] [Related]
15. SVVYGLR motif of the thrombin-cleaved N-terminal osteopontin fragment enhances the synthesis of collagen type III in myocardial fibrosis.
Uchinaka A; Hamada Y; Mori S; Miyagawa S; Saito A; Sawa Y; Matsuura N; Yamamoto H; Kawaguchi N
Mol Cell Biochem; 2015 Oct; 408(1-2):191-203. PubMed ID: 26112906
[TBL] [Abstract][Full Text] [Related]
16. Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage.
Yamaguchi Y; Shao Z; Sharif S; Du XY; Myles T; Merchant M; Harsh G; Glantz M; Recht L; Morser J; Leung LL
J Biol Chem; 2013 Feb; 288(5):3097-111. PubMed ID: 23204518
[TBL] [Abstract][Full Text] [Related]
17. Recombinant Osteopontin Improves Neurological Functional Recovery and Protects Against Apoptosis via PI3K/Akt/GSK-3β Pathway Following Intracerebral Hemorrhage.
Zhang W; Cui Y; Gao J; Li R; Jiang X; Tian Y; Wang K; Cui J
Med Sci Monit; 2018 Mar; 24():1588-1596. PubMed ID: 29550832
[TBL] [Abstract][Full Text] [Related]
18. Proangiogenic functions of an RGD-SLAY-containing osteopontin icosamer peptide in HUVECs and in the postischemic brain.
Lee H; Jin YC; Kim SW; Kim ID; Lee HK; Lee JK
Exp Mol Med; 2018 Jan; 50(1):e430. PubMed ID: 29350679
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer.
Shojaei F; Scott N; Kang X; Lappin PB; Fitzgerald AA; Karlicek S; Simmons BH; Wu A; Lee JH; Bergqvist S; Kraynov E
J Exp Clin Cancer Res; 2012 Mar; 31(1):26. PubMed ID: 22444159
[TBL] [Abstract][Full Text] [Related]
20. Identification of the phosphorylated sites of metabolically 32P-labeled osteopontin from cultured chicken osteoblasts.
Salih E; Ashkar S; Gerstenfeld LC; Glimcher MJ
J Biol Chem; 1997 May; 272(21):13966-73. PubMed ID: 9153260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
